MacroGenics (MGNX) Reports Q1 Loss, Lags Revenue Estimates

  • MacroGenics (MGNX) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $0.84 per share a year ago.